Basic HTML Version
Ελληνική Ακτινολογία, Τόμος 43, Τεύχος 4, 2012
246
weighted and perfusion MR imaging for brain tumor
characterization and assessment of treatment response.
Radiology 2006; 239(3):632–49.
3. Mardor Y, Pfeffer R, Spiegelmann R, et al. Early detection
of response to radiation therapy in patients with brain
malignancies using conventional and high b-value
diffusion-weighted magnetic resonance imaging. J Clin
Oncol 2003;21:1094–100.
4. Reddy JS, Mishra AM, Behari S, et al. The role of
diffusion-weighted imaging in the differential diagnosis
of intracranial cystic mass lesions: a report of 147 lesions.
Surg Neurol 2006;66(3):246–50.
5. Mishra AM, Gupta RK, Jaggi RS, et al. Role of diffusion-
weighted imaging and in vivo proton magnetic resonance
spectroscopy in thedifferential diagnosisof ring-enhancing
intracranial cystic mass lesions. J Comput Assist Tomogr
2004;28(4):540–7.
6. Erdogan C, Hakyemez B, Yildirim N, et al. Brain abscess
and cystic brain tumor: discrimination with dynamic
susceptibility contrast perfusion-weighted MRI. J Comput
Assist Tomogr 2005;29(5):663–7.
7. Tsui EY, Leung WH, Chan JH, et al. Tumefactive
demyelinating lesions by combined perfusion-weighted
and diffusion weighted imaging. Comput Med Imaging
Graph 2002;26(5): 343–6.
8. Guo AC, Cummings TJ, Dash RC, et al. Lymphomas
and high-grade astrocytomas: comparison of water
diffusibility and histologic characteristics. Radiology
2002;224:177–83.
9. Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion
MR imaging in enhancing malignant cerebral tumors. Eur
J Radiol 2006;58(3):394–403.
10. Okamoto K, Ito J, Ishikawa K, et al. Diffusion-weighted
echo-planar MR imaging in differential diagnosis of
brain tumors and tumor-like conditions. Eur Radiol
2000;10:1342–50.
11. Toh CH, Chen YL, Hsieh TC, et al. Glioblastoma
multiforme with diffusion-weighted magnetic resonance
imaging characteristics mimicking primary lymphoma.
Case report. J Neurosurg 2006;105:132–5.
12. Krabbe K, Gideon P, Wagn P, et al.MRdiffusion im-
aging of human intracranial tumours. Neuroradiology
1997;39(7):483–9.
13. Kotsenas AL, Roth TC, Manness WK, et al. Abnormal
diffusion-weightedMRI inmedulloblastoma:doesit reflect
small cell histology? Pediatr Radiol 1999;29(7):524–6.
14. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion
magnetic resonance imaging: an early surrogate marker
of therapeutic efficacy in brain tumors. J Natl Cancer Inst
2000; 92(24):2029–36.
15. Chenevert TL, McKeever PE, Ross BD. Monitoring early
response of experimental brain tumors to therapy using
diffusion magnetic resonance imaging. Clin Cancer Res
1997;3(9): 1457–66.
16. Filippi CG, Edgar MA, Ulug AM, et al. Appearance of
meningiomas on diffusion-weighted images: correlating
diffusion constants with histopathologic findings. AJNR
Am J Neuroradiol 2001;22(1):65–72.
17. Hayashida Y, Hirai T, Morishita S, et al. Diffusion-
weighted imagingofmetastaticbrain tumors: comparison
with histologic type and tumor cellularity. AJNR Am J
Neuroradiol 2006;27(7):1419–25.
18. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of
diffusion-weighted MRI with echoplanar technique in
the evaluation of cellularity in gliomas. J Magn Reson
Imaging 1999; 9:53–60.
19. Catalaa I, Henry R, Dillon WP, et al. Perfusion, diffusion
and spectroscopy values in newly diagnosed cerebral
gliomas. NMR Biomed 2006;19(4):463–75.
20. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas:
prospective comparison of multivoxel 2D chemical-
shift imaging protonMRspectroscopy, echoplanar
perfusion and diffusion-weighted MRI. Neuroradiology
2002;44:656–66.
21. Bulakbasi N, Kocaoglu M, Ors F, et al. Combination
of single-voxel proton MR spectroscopy and apparent
diffusion coefficient calculation in the evaluation
of common brain tumors. AJNR Am J Neuroradiol
2003;24:225–33.
22. Castillo M, Smith JK, Kwock L, et al. Apparent diffusion
coefficients in the evaluation of high-grade cerebral
gliomas. AJNR Am J Neuroradiol 2001;22:60–4.
23. Mardor Y, Roth Y,Ochershvilli A, et al.Pretreatment
prediction of brain tumors’ response to radiation therapy
using high b-value diffusion-weightedMRI. Neoplasia
2004;6(2):136–42.
24. Khan RB, Gutin PH, Rai SN, et al. Use of diffusion
weightedmagnetic resonance imaging in predicting early
postoperative outcome of new neurological deficits after
brain tumor resection. Neurosurgery 2006;59(1):60–6.
25. SchaeferPW,GrantPE,GonzalezRG.Diffusion-weighted
MR imaging of the brain. Radiology 2000;217:331–
45.
26. Hein PA, Eskey CJ, Dunn JF, et al. Diffusion-weighted
imaging in the follow-up of treated high-grade gliomas:
tumor recurrence versus radiation injury. AJNR Am J
Neuroradiol 2004;25:201–9.
27. Chan YL, Yeung DK, Leung SF, et al. Diffusion-weighted
magnetic resonance imaging in radiation-induced
cerebral necrosis. Apparent diffusion coefficient in lesion
components. J Comput Assist Tomogr 2003;27(5):674–
80.
28. Tsui EY, Chan JH, Ramsey RG, et al. Late temporal lobe
necrosis in patients with nasopharyngeal carcinoma:
evaluation with combined multi-section diffusion
weighted and perfusion weighted MR imaging. Eur J
Radiol 2001;39(3):133–8.
29. Bastin ME, Carpenter TK, Armitage PA, et al. Effects
of dexamethasone on cerebral perfusion and water
diffusion in patients with high-grade glioma. AJNR Am
J Neuroradiol 2006;27(2):402–8.
30. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional
diffusion map: a noninvasive MRI biomarker for early
stratification of clinical brain tumor response. Proc Natl
Acad Sci U S A 2005;102(15):5524–9.
31. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation